Cartridge-Based C. difficile Toxin Detection System
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic tests for Clostridium difficile (C. difficile) infections lack sensitivity and specificity, leading to false positives and unnecessary antibiotic therapy, as well as increased healthcare costs.
Innovation Solution
A method and device for detecting C. difficile toxins in stool samples using a cartridge-based system that requires minimal sample preparation, involving the use of fluorescent and magnetic particles coated with antibodies that bind specifically to toxin A and toxin B, and a dye-cushion to enhance signal-to-noise ratios.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If nucleic acid amplification tests are used to detect C. difficile genome, then clinical sensitivity is improved, but clinical specificity deteriorates due to false positives from colonized patients
Solution Approach 1:
The diagnostic approach is segmented into two independent detection targets: C. difficile genome detection (using NAATs for sensitivity) and toxin detection (using immunoassays for specificity). This segmentation allows each test to optimize for its specific function while their combination provides both sensitivity and specificity.
Solution Approach 2:
The patent combines nucleic acid amplification testing and toxin immunoassaying into a single diagnostic workflow. By merging these two detection methods, the system achieves both high sensitivity (from NAATs) and high specificity (from toxin detection), resolving the contradiction between sensitivity and specificity.
2Ease of operation
If rapid commercial immunoassays are used to detect C. difficile toxins, then ease of operation is improved, but measurement precision deteriorates due to insufficient sensitivity
Solution Approach 1:
The patent introduces a cartridge-based system as an intermediary platform that integrates both NAAT and immunoassay components. This intermediary system provides the ease of operation of rapid tests while achieving the sensitivity of more sophisticated methods through automated, integrated processing.
Solution Approach 2:
The patent changes the detection parameters by using multiple detection modalities (nucleic acid amplification and toxin immunoassay) within the same test system. This allows the system to achieve high analytical sensitivity while maintaining rapid operation, as both detection methods are performed in parallel within the cartridge.
3Measurement precision
If Cell Cytotoxicity Neutralization Assay is used for toxin detection, then measurement precision is improved, but productivity deteriorates due to long test time
Solution Approach 1:
The patent performs preliminary action by pre-coating the cartridge with reagents and establishing the detection matrix before sample analysis. This preliminary preparation allows the Cell Cytotoxicity Neutralization Assay to be performed rapidly without requiring time-consuming sample preparation or complex processing steps during the actual test.
Solution Approach 2:
The patent replaces manual mechanical operations with automated cartridge-based processing. The automated system performs the neutralization assay steps automatically, eliminating manual transfer, mixing, and observation steps that would otherwise extend the test time, thus improving productivity while maintaining detection accuracy.
4Measurement precision
If nucleic acid-based assays are used for C. difficile detection, then clinical sensitivity is improved, but device complexity increases
Solution Approach 1:
The patent merges the NAAT and immunoassay components into a single integrated cartridge system. This consolidation reduces device complexity by eliminating the need for separate instruments for each test, while maintaining the high clinical sensitivity provided by nucleic acid amplification.
Solution Approach 2:
The patent uses a cartridge-based system that replicates the functionality of complex laboratory instruments in a simplified, portable format. The cartridge contains all necessary reagents and processing channels, allowing NAAT to be performed without requiring complex thermal cyclers or specialized equipment, thus reducing device complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves high analytical sensitivity, with detection limits of 45 pg/ml for toxin B and 365 pg/ml for toxin A, and demonstrates equivalence in performance to the Cell Cytotoxicity Neutralization Assay, while reducing hands-on time, cost, and simplifying instrumentation.
Implementation Method 1
The cartridge is placed over a magnet which draws all of the magnetic particles through the dye-cushion layer, depositing the magnetic particles on the detection surface of the imaging well
Implementation Method 2
The dye-cushion functions to optically sequester the sample and unbound fluorescent labels from the detection surface
Data Source
AI summary
Methods and cartridges for detecting targets are provided. A biological sample is introduced to a cartridge. Targets in the sample are photonically labeled with fluorescent particles in a first liquid layer in the cassette. Photonically-labeled targets are separated out of the sample into a second liquid layer within the cassette, detected, and counted to show presence of the targets in the subject. Cartridges include a receiving reservoir, a mixing well for introducing the sample to photonic labels and magnetic particles, and an imaging well for detecting and counting targets from the sample. The sample may be a human stool sample. A filter may be used to filter particulates out of the sample.